Sofinnova Investments, Inc. Q3 2021 Filing
Filed November 15, 2021
Portfolio Value
$1.7T
Holdings
70
Report Date
Q3 2021
Filing Type
13F-HR
All Holdings (70 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera Inc | 3,102,960 | $345.8B | 20.48% | |
| 2 | KRTXKaruna Therapeutics, Inc. | 1,953,077 | $238.9B | 14.15% | |
| 3 | ASNDAscendis Pharma A/S | 499,824 | $79.7B | 4.72% | |
| 4 | AVTEAerovate Therapeutics, Inc. | 3,758,686 | $78.9B | 4.67% | |
| 5 | AZNAstraZeneca PLC | 1,128,272 | $67.8B | 4.01% | |
| 6 | YMABUSDY-mAbs Therapeutics, Inc. | 2,194,278 | $62.6B | 3.71% | |
| 7 | VERAVera Therapeutics, Inc. | 2,914,776 | $50.6B | 2.99% | |
| 8 | MRKMerck & Co Inc | 600,000 | $45.1B | 2.67% | Call |
| 9 | UTHUnited Therapeutics Corp | 222,094 | $41.0B | 2.43% | |
| 10 | BOLT1EURBolt Biotherapeutics, Inc. | 2,754,437 | $34.8B | 2.06% | |
| 11 | AFWAlign Technology Inc | 47,000 | $31.3B | 1.85% | |
| 12 | ABBVAbbvie Inc | 272,600 | $29.4B | 1.74% | |
| 13 | GRTXGalera Therapeutics, Inc. | 3,083,712 | $25.0B | 1.48% | |
| 14 | HRTXHeron Therapeutics Inc | 2,301,179 | $24.6B | 1.46% | |
| 15 | BMYBristol-Myers Squibb Co | 400,000 | $23.7B | 1.40% | Call |
| 16 | INZYInozyme Pharma, Inc. | 2,028,308 | $23.5B | 1.39% | |
| 17 | DC4Dexcom Inc | 37,266 | $20.4B | 1.21% | |
| 18 | 2L9Blueprint Medicines Corp | 181,860 | $18.7B | 1.11% | |
| 19 | REGNRegeneron Pharmaceuticals | 30,000 | $18.2B | 1.08% | Put |
| 20 | NXTCNextcure, Inc | 2,671,856 | $18.0B | 1.07% | |
| 21 | —Akouos, Inc. | 1,515,074 | $17.6B | 1.04% | |
| 22 | UTHRUnited Therapeutics Corp | 94,500 | $17.4B | 1.03% | Put |
| 23 | HZNPHorizon Therapeutics Pub L | 157,487 | $17.3B | 1.02% | |
| 24 | RETAEURReata Pharmaceuticals Inc | 157,488 | $15.8B | 0.94% | |
| 25 | CYTKCytokinetics Inc | 426,632 | $15.2B | 0.90% | |
| 26 | —ObsEva SA | 4,749,623 | $14.8B | 0.87% | |
| 27 | ZTSZoetis Inc | 76,000 | $14.8B | 0.87% | |
| 28 | IM8NInsmed Inc | 535,120 | $14.7B | 0.87% | |
| 29 | SRPTSarepta Therapeutics, Inc. | 157,279 | $14.5B | 0.86% | |
| 30 | —Nucana Plc | 5,599,999 | $14.4B | 0.86% | |
| 31 | —Checkmate Pharmaceuticals Inc | 3,606,707 | $14.3B | 0.85% | |
| 32 | KURAKura Oncology Inc | 755,121 | $14.1B | 0.84% | |
| 33 | AGENEURAgenus Inc | 2,344,410 | $12.3B | 0.73% | |
| 34 | —Zymeworks Inc | 410,619 | $11.9B | 0.71% | |
| 35 | TVTXTravere Therapeutics Inc | 437,280 | $10.6B | 0.63% | |
| 36 | EX9Exelixis Inc | 488,414 | $10.3B | 0.61% | |
| 37 | MRTXEURMirati Therapeutics Inc | 56,900 | $10.1B | 0.60% | |
| 38 | BIIBBiogen Inc | 33,220 | $9.4B | 0.56% | |
| 39 | —Kadmon Holdings Inc | 1,046,312 | $9.1B | 0.54% | |
| 40 | CCXIEURChemoCentryx Inc | 517,708 | $8.9B | 0.52% | |
| 41 | —ChemoCentryx Inc | 505,800 | $8.6B | 0.51% | Put |
| 42 | PTCTPTC Therapeutics Inc | 230,019 | $8.6B | 0.51% | |
| 43 | ITCIEURIntra-Cellular Therapies Inc | 227,419 | $8.5B | 0.50% | |
| 44 | ALXOALX Oncology Holdings Inc | 107,220 | $7.9B | 0.47% | |
| 45 | SNDXSyndax Pharmaceuticals Inc | 413,841 | $7.9B | 0.47% | |
| 46 | TCE2Celldex Therapeutics, Inc. | 137,032 | $7.4B | 0.44% | |
| 47 | XLRNAcceleron Pharma Inc | 39,589 | $6.8B | 0.40% | |
| 48 | IMTXImmatics N.V | 478,216 | $6.2B | 0.37% | |
| 49 | —Nucana Plc | 2,400,000 | $6.2B | 0.37% | |
| 50 | CTIC1USDCTI BioPharma Corp | 2,074,714 | $6.1B | 0.36% | |
| 51 | OPHTEURIveric Bio Inc | 357,400 | $5.8B | 0.34% | |
| 52 | AMRNAmarin Corp | 1,069,968 | $5.5B | 0.32% | |
| 53 | RGNXRegenxbio Inc | 127,593 | $5.3B | 0.32% | |
| 54 | PTGXProtagonist Therapeutics Inc | 300,000 | $5.3B | 0.31% | Call |
| 55 | PTGXProtagonist Therapeutics Inc | 297,709 | $5.3B | 0.31% | |
| 56 | GHGuardant Health Inc | 40,000 | $5.0B | 0.30% | |
| 57 | JNCEEURJounce Therapeutics Inc | 637,347 | $4.7B | 0.28% | |
| 58 | —Sierra Oncology, Inc. | 206,564 | $4.5B | 0.27% | |
| 59 | CYTCyteir Therapeutics, Inc. | 246,321 | $4.3B | 0.26% | |
| 60 | —Iveric Bio Inc | 255,300 | $4.1B | 0.25% | Put |
| 61 | NVCRNovocure Ltd | 30,000 | $3.5B | 0.21% | Call |
| 62 | —Intercept Pharmaceuticals In | 190,000 | $2.8B | 0.17% | Call |
| 63 | QUREUniqure NV | 78,742 | $2.5B | 0.15% | |
| 64 | PDSBPDS Biotechnology Corporation | 142,635 | $2.1B | 0.13% | |
| 65 | ALGSAligos Therapeutics Inc | 124,342 | $1.9B | 0.11% | |
| 66 | MRNS*Marinus Pharmaceuticals Inc | 166,711 | $1.9B | 0.11% | |
| 67 | —Synlogic Inc. | 574,972 | $1.8B | 0.10% | |
| 68 | FULCFulcrum Therapeutics Inc | 51,006 | $1.4B | 0.09% | |
| 69 | —Fusion Pharmaceuticals Inc | 78,066 | $618.0M | 0.04% | |
| 70 | PODDInsulet Corp | 1,066 | $303.0M | 0.02% |